- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Pharmacokinetics, Plasma Concentrations & Clinical Relevance

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Pharmacokinetics, Plasma Concentrations & Clinical Relevance
This is a Virtual Event for PsychU members in DC, Delaware, Maryland, New York, North Carolina, Pennsylvania, South Carolina, Virginia, and West Virginia.
Pharmacokinetics refers to the study of how drugs are processed by the body. These processes play an important role in mental health treatments, and can vary due to several factors, ultimately impacting treatment of mental health. In this program, we will first provide an overview of pharmacokinetics and pharmacodynamics. Then, we will discuss the differences between pharmacokinetics based on different medication formulations, including the differences between oral and long-acting injectable formulations. Finally, the importance of pharmacokinetics and plasma concentration monitoring will be discussed as it relates to the clinical setting.

Miranda Fisher, PhD
Medical Science Liaison

Dennis Sholler, PhD (OPDC)
Senior Medical Science Liaison, CNS

Amica Simmons-Yon, PharmD, PhD
Senior Medical Science Liaison, Neuroscience Field Medical Affairs
Speakers Miranda Fisher, PhD; Dennis Sholler, PhD; and Amica Simmons-Yon, PharmD, PhD are employees for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)